Achieve Life Sciences Inc ACHV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 05/03/24 EDT
4.74quote price arrow up+0.04 (+0.96%)
Volume
75,809
52 week range
3.03 - 10.30
Loading...
  • Open4.73
  • Day High4.80
  • Day Low4.62
  • Prev Close4.69
  • 52 Week High10.30
  • 52 Week High Date05/11/23
  • 52 Week Low3.03
  • 52 Week Low Date12/12/23

Key Stats

  • Market Cap162.183M
  • Shares Out34.25M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change14.93

KEY STATS

  • Open4.73
  • Day High4.80
  • Day Low4.62
  • Prev Close4.69
  • 52 Week High10.30
  • 52 Week High Date05/11/23
  • 52 Week Low3.03
  • 52 Week Low Date12/12/23
  • Market Cap162.183M
  • Shares Out34.25M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change14.93

RATIOS/PROFITABILITY

  • EPS (TTM)-1.53
  • P/E (TTM)-3.10
  • Fwd P/E (NTM)-4.51
  • EBITDA (TTM)-26.893M
  • ROE (TTM)-869.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-927.95%
  • Debt To Equity (MRQ)-1,150.69%

EVENTS

  • Earnings Date05/09/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Achieve Life Sciences Inc

 

Profile

MORE
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring, plant-based alkaloid. Cytisinicline is structurally similar to nicotine and has a well-defined, dual-acting mechanism of action that is both agonistic and antagonistic. Cytisinicline is a partial agonist...
Richard Stewart
Executive Chairman of the Board
John Bencich CPA
Chief Executive Officer, Director
Cindy Jacobs M.D., Ph.D
President, Director, Chief Medical Officer
Jerry Wan
Principal Accounting Officer, Senior Director, Accounting Operations
Address
22722 29TH DR. SE, SUITE 100
Seattle, WA
98021
United States

Top Peers

SYMBOLLASTCHG%CHG
GOSS
Gossamer Bio Inc
0.74-0.0313-4.0581%
RANI
Rani Therapeutics Holdings Inc
7.15+0.78+12.24%
RGLS
Regulus Therapeutics Inc
2.65-0.04-1.49%
ACET
Adicet Bio Inc
1.45+0.04+2.84%
PRAX
Praxis Precision Medicines Inc
54.54+0.38+0.70%